...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trial
1
Dec 10, 2019 03:57PM
1
Dec 10, 2019 09:20PM

Hi Bear can you update me I have tried IR as to when the trial results will be revealed they say future conference orvpublication.Any ideas 're conference?

3
Feb 09, 2020 11:00AM
5
Feb 13, 2020 02:57PM
Share
New Message
Please login to post a reply